Ad is loading...
DBIVX
Price
$10.14
Change
-$0.04 (-0.39%)
Updated
Nov 15 closing price
PASCX
Price
$11.01
Change
-$0.03 (-0.27%)
Updated
Nov 15 closing price
Ad is loading...

DBIVX vs PASCX

Header iconDBIVX vs PASCX Comparison
Open Charts DBIVX vs PASCXBanner chart's image
DWS Global Macro S
Price$10.14
Change-$0.04 (-0.39%)
VolumeN/A
CapitalizationN/A
PIMCO All Asset C
Price$11.01
Change-$0.03 (-0.27%)
VolumeN/A
CapitalizationN/A
DBIVX vs PASCX Comparison Chart
Loading...
View a ticker or compare two or three
VS
DBIVX vs. PASCX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DBIVX is a StrongBuy and PASCX is a Hold.

FUNDAMENTALS
Fundamentals
PASCX has more cash in the bank: 12B vs. DBIVX (170M). PASCX pays higher dividends than DBIVX: PASCX (2.69) vs DBIVX (1.75). DBIVX was incepted earlier than PASCX: DBIVX (20 years) vs PASCX (22 years). PASCX is a more actively managed with annual turnover of: 73.00 vs. DBIVX (48.00). PASCX has a lower initial minimum investment than DBIVX: PASCX (1000) vs DBIVX (2500). PASCX annual gain was more profitable for investors over the last year : 9.10 vs. DBIVX (7.12). PASCX return over 5 years is better than : 21.37 vs. DBIVX (14.35).
DBIVXPASCXDBIVX / PASCX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence20 years22 years-
Gain YTD3.5223.322106%
Front LoadN/AN/A-
Min. Initial Investment25001000250%
Min. Initial Investment IRAN/AN/A-
Net Assets170M12B1%
Annual Yield % from dividends1.752.6965%
Returns for 1 year7.129.1078%
Returns for 3 years3.99-3.02-132%
Returns for 5 years14.3521.3767%
Returns for 10 years45.5336.39125%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TMP75.450.78
+1.04%
Tompkins Financial Corp
FIBK33.14-0.14
-0.42%
First Interstate BancSystem
OVV43.79-0.93
-2.08%
Ovintiv
EXFY2.75-0.11
-3.85%
Expensify
MBRX2.71-0.38
-12.30%
Moleculin Biotech